Hepatitis B Virus Infection
15
5
5
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
6.7%
1 terminated out of 15 trials
75.0%
-11.5% vs benchmark
47%
7 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (15)
The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B
Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B
Strengthening Hepatitis B Screening, Linkage to Care and Long-Term Monitoring in Phichit Province, Thailand: A Birth Bohort Approach
HBV Virions Bound Proteins
Using Flavonoids to Kill Hepatitis B Virus
Optimal Timing of Hepatitis B Vaccination After Transplants
A Non-interventional Registry for Patients with Hepatitis B Virus Infection
Hepatitis B Vaccination After Neonatal Surgery
Treatment and Prognosis of Patients With Chronic HBV Infection
A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus
Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)